Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.

Palshof, Jesper Andreas

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer. [electronic resource] - BMC cancer 01 2017 - 48 p. digital

Publication Type: Journal Article

1471-2407

10.1186/s12885-016-3001-y doi


Aged
Antineoplastic Agents, Phytogenic--therapeutic use
Biomarkers, Tumor
Camptothecin--analogs & derivatives
Colorectal Neoplasms--drug therapy
DNA Topoisomerases, Type I--genetics
Disease-Free Survival
Female
Gene Dosage
Humans
Irinotecan
Liver Neoplasms--secondary
Lung Neoplasms--secondary
Male
Middle Aged
Treatment Outcome